Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells

DOI: 10.1080/2162402X.2015.1115940

Keywords: Chimeric antigenic receptor, lenalidomide, lymphoma, tumor immunotherapy, T cells

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text